Vivos Inc. Expands Cancer Treatment Options with IsoPet Therapy

Author: Kelly Martin Updated: 05-15-2025 08:58 AM

Vivos Inc. Expands Cancer Treatment Options for Pets

Kennewick, WA – Vivos Inc. (OTCQB: RDGL) has unveiled an exciting advancement in animal healthcare. The University of Florida Veterinary Hospital is now officially certified to administer IsoPet® Precision Radionuclide Therapy™, a pioneering treatment specifically designed to combat cancer in pets.

Innovative Therapy for Pets

With the certification of the University of Florida Veterinary Hospital, pet owners now have access to IsoPet® therapy, which represents a significant step forward in veterinary oncology. This method employs a proprietary radionuclide injection aimed at treating solid tumors in a manner that is both targeted and minimally invasive compared to traditional treatments.

A Commitment to Veterinary Excellence

Dr. Michael Korenko, President and CEO of Vivos Inc., expressed enthusiasm regarding the certification of this prestigious institution. He stated, "Our goal is to grow the network of certified clinics offering IsoPet therapy across the country. Each certification represents a step toward broader access to a treatment that is both effective and far less invasive than traditional options. The University of Florida team has demonstrated the clinical rigor and enthusiasm needed to offer this innovative therapy."

Supporting Animal Health Facilities

Vivos Inc. plays an instrumental role in this process by aiding clinics through the licensing journey. The company also provides extensive training for the management teams within these facilities, ensuring they are competent and fully equipped to administer IsoPet safely and effectively. With additional veterinary hospitals currently in the certification phase, the reach of this advanced treatment is set to broaden.

Connecting with Vivos Inc.

For any inquiries or further information, you can contact Dr. Michael K. Korenko, Sc.D., President & CEO of Vivos Inc. If you wish to reach out via email, please write to MKorenko@RadioGel.com. For more updates, connect with Vivos Inc. on X (Twitter) @VivosIncUSA.

Learn More

To understand more about IsoPet® therapy and the innovative RadioGel® solutions provided by Vivos Inc., visit their official website at VivosInc.com.

Frequently Asked Questions

What is IsoPet® Precision Radionuclide Therapy?

IsoPet® Precision Radionuclide Therapy is an innovative cancer treatment for animals, utilizing targeted radionuclide injections to treat solid tumors.

Which veterinary hospital has been certified by Vivos Inc.?

The University of Florida Veterinary Hospital is the latest facility certified to offer IsoPet® therapy for pets.

How does Vivos Inc. support veterinary hospitals?

Vivos Inc. assists veterinary hospitals through the certification process and provides comprehensive training for the staff.

Is IsoPet therapy invasive?

No, IsoPet therapy is minimally invasive compared to traditional cancer treatment methods, making it a preferable option for many pet owners.

Can more veterinary hospitals become certified?

Yes, Vivos Inc. is currently working with additional veterinary hospitals to achieve certification, expanding treatment availability.

About The Author

Hello Kelly Martin here, a financial and publicly traded company specialist committed to writing with clarity and sage advice. Having a wealth of experience and a thorough grasp of corporate dynamics and the financial environment, my main goal in writing blog posts and articles is to provide insightful analysis together with useful guidance. My objective is to arm readers with the information they need to comprehend the complexities of publicly traded companies and make wise financial decisions.

Writing for several financial blogs has let me interact with a wide range of readers, from novice investors to seasoned pros looking for fresh perspectives. My goal is to make corporate analysis and finance understandable and interesting so you may confidently negotiate the intricacies of the financial world. I appreciate you traveling with me toward success and financial literacy.

Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.